EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles

Eva Habjan iD, Alexander Lepioshkin, Vicky Charitou, Anna Egorova iD, Elena Kazakova, Vien Qt Ho iD, Wilbert Bitter, Vadim Makarov iD, Alexander Speer iD

Life Science Alliance · 2024

DOI: 10.26508/lsa.202302509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Eva Habjan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: Zebrafish, Benzothiazoles, Drug Synergism, Mycobacterium marinum. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing effective tuberculosis drugs is hindered by mycobacteria’s intrinsic antibiotic resistance because of their impermeable cell envelope. Using benzothiazole compounds, we aimed to increase mycobacterial cell envelope permeability and weaken the defenses of Mycobacterium marinum , serving as a model for Mycobacterium tuberculosis . Initial hit, BT-08, significantly boosted ethidium bromide uptake, indicating enhanced membrane permeability. It also demonstrated efficacy in the M. marinum –zebrafish embryo infection model and M. tuberculosis -infected macrophages. Notably, BT-08 synergized with established antibiotics, including vancomycin and rifampicin. Subsequent medicinal chemistry optimization led to BT-37, a non-toxic and more potent derivative, also enhancing ethidium bromide uptake and maintaining synergy with rifampicin in infected zebrafish embryos. Mutants of M. marinum resistant to BT-37 revealed that MMAR_0407 (Rv0164) is the molecular target and that this target plays a role in the observed synergy and permeability. This study introduces novel compounds targeting a new mycobacterial vulnerability and highlights their cooperative and synergistic interactions with existing antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishBenzothiazolesDrug SynergismMycobacterium marinumAnimalsAntitubercular AgentsMicrobial Sensitivity TestsMycobacterium tuberculosisHumansAnti-Bacterial AgentsCell Membrane PermeabilityMacrophagesMycobacterium Infections, NontuberculousCell MembraneRifampin

Substanzen

BenzothiazolesAntitubercular AgentsAnti-Bacterial AgentsRifampin

Autor:innen und Institutionen

  • Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
  • Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), Moscow, Russia.
  • Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), Moscow, Russia makarov@inbi.ras.ru.
  • Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands a.speer@amsterdamumc.nl.

ORCID-Profile: Eva Habjan, Anna Egorova, Vien Qt Ho, Vadim Makarov, Alexander Speer

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Habjan, E., Lepioshkin, A., Charitou, V., Egorova, A., Kazakova, E., Ho, V. Q., Bitter, W., Makarov, V., & Speer, A. (2024). Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles. Life Science Alliance. https://doi.org/10.26508/lsa.202302509

Vancouver

Habjan E, Lepioshkin A, Charitou V, Egorova A, Kazakova E, Ho VQ, et al. Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles. Life Science Alliance. 2024. doi:10.26508/lsa.202302509

BibTeX
@article{Habjan2024,
  author = {Habjan, Eva and Lepioshkin, Alexander and Charitou, Vicky and Egorova, Anna and Kazakova, Elena and Ho, Vien Qt and Bitter, Wilbert and Makarov, Vadim and Speer, Alexander},
  title = {Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles},
  journal = {Life Science Alliance},
  year = {2024},
  doi = {10.26508/lsa.202302509}
}
Kostenlos starten →